Saturday, March 2, 2024



Eli Lilly, Novo Nordisk, Moderna and Regeneron Post Strong Quarterly Earnings Owing to Successful Development Initiatives

Eli Lilly, Novo Nordisk, Moderna, and Regeneron achieved robust quarterly earnings, attributing it to the success of their drug and pipeline development initiatives. Eli...

Moderna and Caris Life Sciences Join Forces for Advancement in mRNA-Based Oncology Therapeutics Using Health Data

An agreement has been reached where Moderna will use Caris Life Sciences' library of de-identified, multi-modal health data solutions. These solutions have been generated...

Latest news

Sticky Image